US Broker Ratings

Vir Biotechnology, Inc. (VIR) Stock Analysis: Unpacking a 254.66% Potential Upside in the Biotech Sector

Vir Biotechnology, Inc. (NASDAQ: VIR) stands out in the biotechnology sector with an impressive potential upside of 254.66%, according to analyst ratings. This San Francisco-based clinical-stage..

Definitive Healthcare Corp. (DH) Stock Analysis: Unveiling a 13.15% Potential Upside

Definitive Healthcare Corp. (NASDAQ: DH), a key player in the healthcare information services industry, is catching the attention of investors with its substantial potential upside of..

Savara, Inc. (SVRA) Stock Analysis: Exploring a Remarkable 155% Upside Potential in the Biotech Sector

For investors hunting for promising opportunities in the biotechnology sector, Savara, Inc. (NASDAQ: SVRA) presents a compelling case with its significant potential upside. With a market..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Exploring a 75% Potential Upside in the Biotech Arena

Maze Therapeutics, Inc. (NASDAQ: MAZE) is making significant waves in the biotechnology sector, promising investors substantial growth opportunities. With its focus on developing precision medicines, Maze..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Challenges with a 30% Revenue Growth

Sonida Senior Living, Inc. (SNDA), a key player in the healthcare sector, specifically within the medical care facilities industry, operates senior housing communities across the United..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Biotechnology Innovator with a 255% Potential Upside

Relay Therapeutics, Inc. (NASDAQ: RLAY) is making waves in the healthcare sector, specifically within the biotechnology industry. Based in Cambridge, Massachusetts, Relay Therapeutics is a clinical-stage..

Claritev Corporation (CTEV) Stock Analysis: Navigating the Ups and Downs of a Promising Healthcare Player

Claritev Corporation (NASDAQ: CTEV) has emerged as a notable player in the healthcare sector, specializing in health information services. With a market capitalization of $1.17 billion,..

Immatics N.V. (IMTX) Stock Analysis: A Promising Biotech with 158% Potential Upside

Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company based in Germany, has been gaining attention in the investment community for its innovative approach to cancer treatment...

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating Diagnostic Innovations Amidst Market Volatility

Myriad Genetics, Inc. (NASDAQ: MYGN) stands as a pivotal player in the healthcare sector, specifically within the diagnostics and research industry. With a market cap of..

Precigen, Inc. (PGEN) Stock Analysis: Unraveling an 81% Upside Potential in Biotechnology

Investors keen on the biotechnology sector should pay close attention to Precigen, Inc. (NASDAQ: PGEN), a discovery and clinical-stage biopharmaceutical company with a market capitalization of..

Bicycle Therapeutics (BCYC) Stock Analysis: Unpacking a 237.7% Potential Upside in Biotech

Bicycle Therapeutics plc (NASDAQ: BCYC), a pioneering entity in the biotechnology sector, has captured investor attention with a staggering potential upside of 237.7%. This UK-based clinical-stage..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Exploring a Remarkable 244.58% Potential Upside

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) stands out in the biotechnology industry with a compelling investment narrative, particularly for those following the healthcare sector. With a market..

Owens & Minor, Inc. (OMI) Stock Analysis: Navigating Challenges with a 23% Upside Potential

Owens & Minor, Inc. (NYSE: OMI), a stalwart in the healthcare sector, operates as a comprehensive healthcare solutions provider, catering to a broad array of medical..

CareDx, Inc. (CDNA) Stock Analysis: Unlocking a Potential 66% Upside in the Healthcare Sector

CareDx, Inc. (CDNA) is a prominent player in the healthcare sector, focusing on the development and commercialization of diagnostic solutions for transplant patients. With a market..

REGENXBIO Inc. (RGNX) Stock Analysis: Unpacking a 230% Potential Upside in Biotech Innovations

Investors in the biotechnology sector are keeping a keen eye on REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage biotech firm that’s making waves with its promising pipeline..

Auna SA (AUNA) Stock Analysis: Unveiling a 92% Potential Upside for Investors

Auna SA (AUNA), a key player in the healthcare sector, operates across the vibrant landscapes of Mexico, Peru, and Colombia. Specializing in medical care facilities, the..

Mind Medicine (MNMD) Stock Analysis: Exploring a 155.62% Potential Upside in the Biotech Sector

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) offers an intriguing proposition for investors with a high-risk tolerance, given the company’s focus on developing novel treatments for brain..

Orthofix Medical Inc. (OFIX) Stock Analysis: A 52.99% Upside Potential Beckons Investors

Orthofix Medical Inc. (NASDAQ: OFIX), a notable player in the healthcare sector, primarily operates in the medical devices industry. With a market capitalization of $582.15 million,..

uniQure N.V. (QURE) Stock Analysis: Exploring a 128.60% Potential Upside in the Biotech Sector

With a market capitalization of $892.14 million, uniQure N.V. (QURE) presents a compelling case for investors looking to tap into the biotechnology sector’s potential. Headquartered in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds